<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>12</volume><submitter>Jiang Y</submitter><pubmed_abstract>Gastric cancer (GC) is the third leading cause of tumor related mortality worldwide. Peritoneal metastasis (PM) occurs in more than half of advanced GC patients, leading to poor prognosis. Therefore, the GSE62254 cohort was used to construct a signature consisting of four RNA-binding proteins (RBP) to predict the possibility of PM in GC patients. Then, ROC curves were plotted followed by calculation of AUCs, showing that the signature had a similar predictive accuracy compared with the TNM staging system. Importantly, the capability of prediction was enhanced by combining the classifier and TNM staging. In order to validate the expression of the four RBPs in GC tissues with and without PM, immunohistochemistry was further performed on samples from 108 patients. The differential expression </pubmed_abstract><journal>Frontiers in oncology</journal><pagination>830688</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9062106</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>RNA-Binding Protein COL14A1, TNS1, NUSAP1 and YWHAE Are Valid Biomarkers to Predict Peritoneal Metastasis in Gastric Cancer.</pubmed_title><pmcid>PMC9062106</pmcid><pubmed_authors>Jiang Y</pubmed_authors><pubmed_authors>Ren X</pubmed_authors><pubmed_authors>Yang Y</pubmed_authors><pubmed_authors>Tong Q</pubmed_authors><pubmed_authors>Luo J</pubmed_authors><pubmed_authors>Chen F</pubmed_authors><pubmed_authors>Yuan J</pubmed_authors></additional><is_claimable>false</is_claimable><name>RNA-Binding Protein COL14A1, TNS1, NUSAP1 and YWHAE Are Valid Biomarkers to Predict Peritoneal Metastasis in Gastric Cancer.</name><description>Gastric cancer (GC) is the third leading cause of tumor related mortality worldwide. Peritoneal metastasis (PM) occurs in more than half of advanced GC patients, leading to poor prognosis. Therefore, the GSE62254 cohort was used to construct a signature consisting of four RNA-binding proteins (RBP) to predict the possibility of PM in GC patients. Then, ROC curves were plotted followed by calculation of AUCs, showing that the signature had a similar predictive accuracy compared with the TNM staging system. Importantly, the capability of prediction was enhanced by combining the classifier and TNM staging. In order to validate the expression of the four RBPs in GC tissues with and without PM, immunohistochemistry was further performed on samples from 108 patients. The differential expression </description><dates><release>2022-01-01T00:00:00Z</release><publication>2022</publication><modification>2025-04-05T11:42:31.087Z</modification><creation>2025-04-05T11:42:31.087Z</creation></dates><accession>S-EPMC9062106</accession><cross_references><pubmed>35515139</pubmed><doi>10.3389/fonc.2022.830688</doi></cross_references></HashMap>